Showing Patients with Migraine the Possibilities with CGRP mAbs
Showing Patients with Migraine the Possibilities with CGRP mAbs
Clinical CommentaryThis activity focuses on the latest data with calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) as well as personalized migraine treatment. Leading migraine experts, Jessica Ailani, MD, FAHS, FAAN and Richard Wenzel, PharmD discuss factors that influence treatment, strategies to improve therapeutic adherence, and comprehensive care strategies. To accompany this education, a short, patient-centered animated whiteboard is also provided to help frame foundational knowledge about the CGRP mAbs.
Faculty: Jessica Ailani, MD, FAHS, FAAN; Richard Wenzel, PharmD, CPPS
Release Date:
Expiration Date: September 30, 2023
CME/CE is no longer available for this activity
